Abvc Biopharma (ABVC) Convertible Debt (2009 - 2026)
Abvc Biopharma's Convertible Debt came in at $559.01 billion for Q3 2026, up 712.6% from $68.79 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Convertible Debt (2009 - 2026) Analysis & Trends
Going back to Q2 2009, Abvc Biopharma's Convertible Debt data covers 32 quarters.
- Convertible Debt carries a five-year compound annual growth rate of 1074.6% (FY2020 to FY2025).
- Going back by year, Convertible Debt was $950.05 billion in FY2024 and $886,522 in FY2023.
- The five-year range for quarterly Convertible Debt is $872,336 (Q1 2024) to $950.05 billion (Q4 2024).
- Year-over-year, Convertible Debt increased in two of the last four quarters, with growth averaging 189.6%.
- Business Quant data shows ABVC's Convertible Debt at $559.01 billion (Q2 2026), $559.01 billion (Q1 2026) and $559.01 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 559.01 Bn |
| Jun 30, 2026 | 559.01 Bn |
| Mar 31, 2026 | 559.01 Bn |
| Dec 31, 2025 | 559.01 Bn |
| Sep 30, 2025 | 68.79 Bn |
| Jun 30, 2025 | 254.20 Bn |
| Mar 31, 2025 | 835.54 Bn |
| Dec 31, 2024 | 950.05 Bn |
| Mar 31, 2024 | 872,336.00 |
| Dec 31, 2023 | 886,522.00 |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 3.21 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 250,000.00 |
| Jun 30, 2020 | 820,000.00 |
| Mar 31, 2020 | 820,000.00 |
| Dec 31, 2019 | 820,000.00 |
API Access
Abvc Biopharma Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();